Explore more publications!

Asia Healthcare Industry Digest: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Asia Healthcare Industry Digest.

Press releases published on November 17, 2025

JUARA Unveils 2025 Holiday Gift Guide and Limited-Time Black Friday/Cyber Monday Sale
M David Raj and M Square Motivation Empower TRR Institute MBBS Students
Oleoresin Market Poised for Growth, Expected to Hit USD 2.61 Billion by 2032 | Coherent Market Insights
Dr. Mohana Rao Patibandla Presents India’s Largest 1008-Case IONM Study at SIONCON 2025, NIMHANS
Ready-to-Occupy SIL Homes by Kuremara in Melbourne
Coeo Group Selects Bright Pattern's AI-Powered Platform to Transform Debt Collection Operations Across Europe
Artisan Therapeutics and Tulex Pharmaceuticals Announce Positive Phase 2a Results for ART-501, a Novel Oral Liquid Extended-Release Formulation for Autism Spectrum Disorder
Portsmouth Square, Inc. Reports Q1 FY2026 Results; Hotel KPIs Up, Continued Stabilization in San Francisco, and ~$10.1 Million in Cash & Restricted Cash
[CAGR of 6.5%] Face Shield Market to Show Incredible Growth and Forecast by 2031
Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Komzifti™ (ziftomenib)
Avalo Therapeutics Announces Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Eviden-built JUPITER Supercomputer Hits Exascale Milestone According to the TOP500, a First in Europe
Fennec Pharmaceuticals Announces Closing of Offering of Common Shares
Crescent Biopharma Announces Grants of Inducement Awards
Clover Health to Participate in Upcoming 2025 Citi Global Healthcare Conference
Candel Therapeutics to Host Virtual R&D Event on December 5, 2025
Landmark Nature Health Study Demonstrates the Effectiveness of DeepHealth’s Novel AI-Powered Breast Cancer Detection Workflow
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Apyx Medical Corporation Announces Proposed Public Offering of Common Stock
Celcuity Announces Completion of Submission of Its New Drug Application to the U.S. FDA for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions